US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof
Patent 7785816 was granted and assigned to Facet Biotech on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+116 characters)
Article
Patent abstract
Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Agustin de la Calle0
Daniel Afar0
David Powers0
Debbie Law0
Ingrid Caras0
Richard Murray0
Vanitha Ramakrishnan0
Vinay Bhaskar0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07785816 Antibodies against cancer antigen TMEFF2 and uses thereof US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof
Infobox
Patent Number
077858160
Patent Number
77858160
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077858160
Date of Patent
August 31, 2010
0Patent Application Number
118373330
Date Filed
August 10, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07785816 Antibodies against cancer antigen TMEFF2 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07785816
Date of patent
August 31, 2010
Patent application number
11837333
Date Filed
August 10, 2007
Patent primary examiner
Find more entities like US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.